MML Investors Services
AMRX icon

MML Investors Services’s Amneal Pharmaceuticals AMRX Stock Holding History

MML Investors Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
107,857
+18,514
+21% +$254K ﹤0.01% 1582
2026
Q1 		$1.11M Buy
89,343
+6,909
+8% +$92.8K ﹤0.01% 1698
2025
Q4 		$1.04M Buy
82,434
+30,435
+59% +$348K ﹤0.01% 1774
2025
Q3 		$521K Buy
+51,999
New +$467K ﹤0.01% 2150

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

MML Investors Services's AMRX Position: Q2 2026 in Review

MML Investors Services increased its Amneal Pharmaceuticals (AMRX) stake by 21% in Q2 2026, buying an estimated $254K and bringing the position to 107,857 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

MML Investors Services first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • MML Investors Services held 107,857 shares of Amneal Pharmaceuticals worth $1.87M as of Q2 2026.
  • MML Investors Services bought 18,514 Amneal Pharmaceuticals shares in Q2 2026, an estimated $254K.
  • Amneal Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1582 holding.
  • MML Investors Services first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.